CHRM1 and peripheral neuropathy: This review highlights mitochondrial and Ca2+ signaling imbalances in DSPN and presents M1R antagonism and TRPM3 activation as promising neuro-regenerative strategies that shift treatment from symptom control to nerve restoration in diabetic and other peripheral neuropathies.